Claire H Mitchell Selected Research

RNA (Ribonucleic Acid)

8/2006

Identification of the A3 adenosine receptor in rat retinal ganglion cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claire H Mitchell Research Topics

Disease

9	Ganglion Cysts (Ganglion) 01/2016 - 06/2005
8	Glaucoma 05/2015 - 12/2008
5	Retinal Degeneration 11/2020 - 08/2012
4	Inflammation (Inflammations) 01/2021 - 05/2015
3	Pain (Aches) 01/2020 - 11/2007
3	Wounds and Injuries (Trauma) 01/2019 - 10/2014
2	Rupture 10/2018 - 01/2018
2	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 09/2014
2	Alzheimer Disease (Alzheimer's Disease) 09/2015 - 09/2014
2	Ischemia 02/2014 - 06/2008
2	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 10/2011 - 11/2007
1	Bites and Stings (Sting) 01/2021
1	Blindness (Hysterical Blindness) 01/2021
1	Herpes Simplex 01/2021
1	Infections 01/2021
1	Keratitis 01/2021
1	Hemorrhage 01/2019
1	Starvation 10/2018
1	Paresthesia (Dysesthesia) 01/2018
1	Retinal Dystrophies 01/2018
1	Smith-Lemli-Opitz Syndrome 01/2018
1	Neuroinflammatory Diseases 01/2017
1	Nervous System Diseases (Neurological Disorders) 08/2015
1	Overactive Urinary Bladder (Overactive Bladder) 04/2015
1	Abnormal Reflex (Hyperreflexia) 04/2015
1	Optic Neuritis (Retrobulbar Neuritis) 02/2014
1	Cataract (Cataracts) 10/2011
1	Muscular Dystrophies (Muscular Dystrophy) 11/2010

Drug/Important Bio-Agent (IBA)

16	Adenosine Triphosphate (ATP)IBA 01/2021 - 11/2007
5	Retinaldehyde (Retinal)IBA 01/2019 - 08/2012
4	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 09/2010 - 06/2005
3	Purinergic P2X7 ReceptorsIBA 01/2021 - 02/2014
3	Adenosine (Adenocard)FDA LinkGeneric 09/2010 - 07/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2006
2	TicagrelorIBA 01/2019 - 01/2018
2	LipofuscinIBA 01/2019 - 01/2018
2	Purinergic P2Y Receptor AntagonistsIBA 01/2019 - 01/2018
2	CalciumIBA 01/2018 - 11/2010
2	Presenilin-1IBA 09/2015 - 09/2014
2	Glutamic Acid (Glutamate)FDA Link 08/2015 - 06/2008
2	CD39 antigenIBA 05/2015 - 11/2013
2	Proteins (Proteins, Gene)FDA Link 10/2014 - 09/2014
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2010 - 08/2006
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2021
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	HydrocarbonsIBA 01/2021
1	InterferonsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Valine (L-Valine)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Retinal Pigments (Pigments, Visual)IBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 10/2018
1	Acid PhosphataseIBA 10/2018
1	CholesterolIBA 01/2018
1	EnzymesIBA 01/2018
1	Carticaine (Articaine)IBA 01/2018
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018
1	trans- 1,4- Bis(2- chlorobenzaminomethyl)cyclohexane DihydrochlorideIBA 01/2018
1	glycylphenylalanineIBA 01/2018
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2018
1	ThapsigarginIBA 01/2018
1	Local AnestheticsIBA 01/2018
1	InflammasomesIBA 01/2017
1	Interleukin-3 (Interleukin 3)IBA 01/2016
1	gamma-Aminobutyric Acid (GABA)IBA 08/2015
1	Apyrase (ATP Diphosphatase)IBA 04/2015
1	6- N,N- diethyl- beta,gamma- dibromomethylene- D- ATPIBA 04/2015
1	Phenobarbital (Luminal)FDA Link 04/2015
1	Adenosine Triphosphatases (ATPase)IBA 04/2015
1	PurinesIBA 10/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2014
1	Protein Isoforms (Isoforms)IBA 02/2014
1	CytokinesIBA 02/2014
1	Ion Channels (Ion Channel)IBA 02/2014
1	Complement System Proteins (Complement)IBA 02/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2014
1	Messenger RNA (mRNA)IBA 11/2013
1	Neuroprotective AgentsIBA 09/2010
1	4- (2- chloro- 6- (3- chlorobenzylamino)- 9H- purin- 9- yl)- 2,3- dihydroxy- N- methylbicyclo(3.1.0)hexane- 1- carboxamideIBA 09/2010
1	coomassie Brilliant BlueIBA 09/2010
1	4- (3- (4- benzoylpiperazin- 1- yl)- 2- (benzyloxycarbonylamino)- 3- oxopropyl)- 3,5- dimethylphenyl 4-methylbenzenesulfonateIBA 09/2010
1	Saline SolutionIBA 09/2010
1	Coloring Agents (Dyes)IBA 08/2006
1	Complementary DNA (cDNA)IBA 08/2006
1	Fura-2 (Fura 2)IBA 08/2006
1	RNA (Ribonucleic Acid)IBA 08/2006
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 08/2006
1	CaspasesIBA 06/2005
1	YO-PRO 1IBA 06/2005

Therapy/Procedure

1	Microspheres (Microsphere) 01/2021
1	Therapeutics 01/2021
1	Cataract Extraction 11/2007